Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-03

FDA Approved: BRIVARACETAM — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a generic version of brivaracetam (BRIVARACETAM) from Zydus Pharmaceuticals USA Inc. under Original Application ANDA214501.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)